---
category: news
title: "Eli Lilly partners with Shanghai Junshi for COVID-19 cure"
excerpt: "U.S. pharmaceutical Eli Lilly is partnering with Chinese drugmaker Shanghai Junshi Biosciences to develop new antibody therapies for COVID-19, the disease that has sickened 3.6 million people worldwide. The companies will collaborate on therapeutic antibody research that could be used to treat and prevent SARS-COV-2, the virus that causes COVID ..."
publishedDateTime: 2020-05-08T02:54:00Z
webUrl: "https://asia.nikkei.com/Spotlight/Caixin/Eli-Lilly-partners-with-Shanghai-Junshi-for-COVID-19-cure"
type: article
quality: 65
heat: 65
published: false

provider:
  name: NIKKEI
  domain: nikkei.com

topics:
  - Coronavirus in China
  - Coronavirus in Asia
  - Coronavirus

tags:
  - China-Shanghai
  - CN
  - CN-SH

images:
  - url: "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fs3-ap-northeast-1.amazonaws.com%2Fpsh-ex-ftnikkei-3937bb4%2Fimages%2F7%2F8%2F6%2F5%2F26905687-1-eng-GB%2FRTS36YL8.JPG?source=nar-cms&width=1024&height=512&fit=cover&gravity=faces"
    width: 1024
    height: 512
    title: "Eli Lilly partners with Shanghai Junshi for COVID-19 cure"

secured: "wzS/f9U7stFaAlSFifjPpY0szylVe0agyDc4hEUHWDT2ueynX6kD+tvoYwSxy7NFa5I/NTD0PdyVN4fUY1zEmwjrJ5P9AeItls1hjwEXgkqWXLBuDnhkDWWEw6s3fM3tCilUjJz5yBvYbdEn2oFXMNKtuve1qS70QUYbfSEe1UlLALZ+aqLDMAbibrUz0MCbZxqSdXHteDSBjeOFsCu6f3utioDli3BgqPbzaXpXJspYnXgE8Tl4lWEWTse2MXSZ8VuidKRjW8VoXg5vUPXA8NlR5UO0PPfYjf5nKBCPeFscmEajx81fszQXO57YwQ9s;OgIvTyCxXieCKor2je3PWw=="
---

